Prognosis of women with primary breast cancer diagnosed during pregnancy: Results from an international collaborative study

Journal of Clinical Oncology

Volumn 31, Issue 20, 2013, Pages 2532-2539

  Amant, Fréd́eric ^a   Von Minckwitz, Gunter ^b   Han, Sileny N ^a   Bontenbal, Marijke ^k   Ring, Alistair E ^o   Giermek, Jerzy ^p   Wildiers, Hans ^a   Fehm, Tanja ^c   Linn, Sabine C ^l   Schlehe, Bettina ^d   Neven, Patrick ^a   Westenend, Pieter J ^m   Mul̈ler, Volkmar ^e   Van Calsteren, Kristel ^a   Rack, Brigitte ^f   Nekljudova, Valentina ^b   Harbeck, Nadia ^g   Untch, Michael ^h   Witteveen, Petronella O ⁿ   Schwedler, Kathrin ^i,q   Thomssen, Christoph ^j   Van Calster, Ben ^a   Loibl, Sibylle ^b   more..

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b German Breast Group   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^h Helios Kliniken Wismarsche S   (Germany)

ⁱ UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^j MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^k ERASMUS MEDICAL CENTER   (Netherlands)

^l ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^m Laboratory for Pathology   (Netherlands)

ⁿ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^o ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^p Departments of Breast Cancer and Reconstructive Surgery   (Poland)

^q LUZERNER KANTONSSPITAL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; ARTICLE; BELGIUM; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CZECH REPUBLIC; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; GERMANY; HISTOPATHOLOGY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MASTECTOMY; MATERNAL AGE; NETHERLANDS; OVERALL SURVIVAL; POLAND; PREGNANCY; PREGNANT WOMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; UNITED KINGDOM; BREAST TUMOR; CAUSE OF DEATH; COMPARATIVE STUDY; CONFIDENCE INTERVAL; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NEEDLE BIOPSY; PATHOLOGY; PREGNANCY COMPLICATION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REFERENCE VALUE; REGISTER; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME;

ADULT; BELGIUM; BIOPSY, NEEDLE; BREAST NEOPLASMS; CAUSE OF DEATH; COHORT STUDIES; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84883889959     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.45.6335     Document Type: Article

References (44)

1. Smith LH, Danielsen B, Allen ME, Cress R: Cancer associated with obstetric delivery: Results of linkage with the California cancer registry. Am J Obstet Gynecol 189:1128-1135, 2003
2. Van Calsteren K, Heyns L, De Smet F, et al: Cancer during pregnancy: An analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28:683-689, 2010
3. Wallack MK, Wolf JA Jr, Bedwinek J, et al: Gestational carcinoma of the female breast. Curr Probl Cancer 7:1-58, 1983
4. Lethaby AE, O'Neill MA, Mason BH, et al: Overall survival from breast cancer in women pregnant or lactating at or after diagnosis: Auckland Breast Cancer Study Group. Int J Cancer 67:751-755, 1996
5. Cheesman WS: Influence of pregnancy on cancer of the breast. Ann Surg 46:487-488, 1907
6. Haagensen CD, Stout AP: Carcinoma of the breast: II. Criteria of operability. Ann Surg 118:859-870, 1943
7. White TT: Carcinoma of the breast and pregnancy: Analysis of 920 cases collected from the literature and 22 new cases. Ann Surg 139:9-18, 1954
8. Cardonick E, Iacobucci A: Use of chemotherapy during human pregnancy. Lancet Oncol 5:283-291, 2004
9. Amant F, Loibl S, Neven P, et al: Breast cancer in pregnancy. Lancet 379:570-579, 2012
10. Amant F, Van Calsteren K, Halaska MJ, et al: Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: An observational study. Lancet Oncol 13:256-264, 2012
11. Bladström A, Anderson H, Olsson H: Worse survival in breast cancer among women with recent childbirth: Results from a Swedish population-based register study. Clin Breast Cancer 4:280-285, 2003
12. Guinee VF, Olsson H, Möller T, et al: Effect of pregnancy on prognosis for young women with breast cancer. Lancet 343:1587-1589, 1994
13. Tretli S, Kvalheim G, Thoresen S, et al: Survival of breast cancer patients diagnosed during pregnancy or lactation. Br J Cancer 58:382-384, 1988
14. Azim HA Jr, Botteri E, Renne G, et al: The biological features and prognosis of breast cancer diagnosed during pregnancy: A case-control study. Acta Oncol 51:653-661, 2012
15. Mathelin C, Annane K, Treisser A, et al: Pregnancy and post-partum breast cancer: A prospective study. Anticancer Res 28:2447-2452, 2008
16. Johansson AL, Andersson TM, Hsieh CC, et al: Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomarkers Prev 20:1865-1872, 2011
17. Nugent P, O'Connell TX: Breast cancer and pregnancy. Arch Surg 120:1221-1224, 1985
18. Greene FL: Gestational breast cancer: A ten-year experience. South Med J 81:1509-1511, 1988
19. Ezzat A, Raja MA, Berry J, et al: Impact of pregnancy on non-metastatic breast cancer: A case control study. Clin Oncol (R Coll Radiol) 8:367-370, 1996
20. Ibrahim EM, Ezzat AA, Baloush A, et al: Pregnancy-associated breast cancer: A case-control study in a young population with a high-fertility rate. Med Oncol 17:293-300, 2000
21. Beadle BM, Woodward WA, Middleton LP, et al: The impact of pregnancy on breast cancer outcomes in women ≤ 35 years. Cancer 115:1174-1184, 2009
22. Stensheim H, Møller B, van Dijk T, et al: Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: A registry-based cohort study. J Clin Oncol 27:45-51, 2009
23. Halaska MJ, Pentheroudakis G, Strnad P, et al: Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: A matched controlled study. Breast J 15:461-467, 2009
24. Loibl S, Han SN, von Minckwitz G, et al: Treatment of breast cancer during pregnancy: An observational study. Lancet Oncol 13:887-896, 2012
25. Loibl S, von Minckwitz G, Gwyn K, et al: Breast carcinoma during pregnancy: International recommendations from an expert meeting. Cancer 106:237-246, 2006
26. Amant F, Deckers S, Van Calsteren K, et al: Breast cancer in pregnancy: Recommendations of an international consensus meeting. Eur J Cancer 46:3158-3168, 2010
27. Hudis CA, Barlow WE, Costantino JP, et al: Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system. J Clin Oncol 25:2127-2132, 2007
28. White IR, Royston P, Wood AM: Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 30:377-399, 2011
29. Sterne JA, White IR, Carlin JB, et al: Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ 338:b2393, 2009
30. Rubin DB: Using propensity scores to help design observational studies: Application to the tobacco litigation. Health Serv Outcomes Res Methodol 2:169-188, 2001
31. Sauerbrei W, Royston P, Binder H: Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med 26:5512-5528, 2007
32. Austin PC: An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46:399-424, 2011
33. Morgan SL, Todd JL: A diagnostic routine for the detection of consequential heterogeneity of causal effects. Sociol Methodol 38:231-281, 2008
34. van Buuren S: Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 16:219-242, 2007
35. Middleton LP, Amin M, Gwyn K, et al: Breast carcinoma in pregnant women: Assessment of clinicopathologic and immunohistochemical features. Cancer 98:1055-1060, 2003
36. Cardonick E, Dougherty R, Grana G, et al: Breast cancer during pregnancy: Maternal and fetal outcomes. Cancer J 16:76-82, 2010
37. Hahn KM, Johnson PH, Gordon N, et al: Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107:1219-1226, 2006
38. Ring AE, Smith IE, Jones A, et al: Chemotherapy for breast cancer during pregnancy: An 18-year experience from five London teaching hospitals. J Clin Oncol 23:4192-4197, 2005
39. Rossouw JE, Anderson GL, Prentice RL, et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333, 2002
40. Schedin P: Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 6:281-291, 2006
41. Lyons TR, Schedin PJ, Borges VF: Pregnancy and breast cancer: When they collide. J Mammary Gland Biol Neoplasia 14:87-98, 2009
42. Janerich DT, Hoff MB: Evidence for a crossover in breast cancer risk factors. Am J Epidemiol 116:737-742, 1982
43. Borges VF, Schedin PJ: Pregnancy-associated breast cancer: An entity needing refinement of the definition. Cancer 118:3226-3228, 2012
44. Van Calsteren K, Verbesselt R, Ottevanger N, et al: Pharmacokinetics of chemotherapeutic agents in pregnancy: A preclinical and clinical study. Acta Obstet Gynecol Scand 89:1338-1345, 2010